Learn More
Medchemexpress LLC Carboxyatractyloside tripotassium | 77228-71-8 | 885.09 | 5 MG

Supplier: Medchemexpress LLC HYN15025MG
Carboxyatractyloside tripotassium is a diterpenoid that can be isolated from plants of the genus Xanthium. It functions as an ADP/ATP carrier inhibitor, specifically inhibiting mitochondrial ADP/ATP transport. This compound promotes ROS production, induces Ca2+ release, and leads to mitochondrial dysfunction, and has been observed to induce lethargy, weakness, and epileptic seizures in rats.
- Promotes cell death in primary mouse lung endothelial cells.
- Exacerbates mitochondrial dysfunction, including depolarization, increased ROS generation, and MPT pore opening.
- Induces Ca2+ release, mitochondrial swelling, and membrane potential collapse in aged rat liver mitochondria.
- Causes histopathological damage to the liver and kidneys, including vacuolar degeneration and necrosis of hepatocytes and renal tubular necrosis.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.